and are key mediators of antigen-independent IFN-g production in response to various stimuli, such as tumor cells and cytokines. 1, 2 Interestingly, this subset has been reported to mediate both natural cytotoxicity and major histocompatibility complex class II-mediated antigen presentation to T cells. 1 IKDCs, through a direct tumoricidal activity, have been implicated in the innate immunotherapeutic effects of a combination of interleukin (IL)-2 plus imatinib against B16F10-derived melanomas. 2 Previous reports had also postulated the existence of a population of cells sharing some of the functional and phenotypical features of both NK cells and DCs in mice, 3 mainly on the basis of CD11c and NK1.1 coexpression. There is evidence that these so-called NKDCs (that comprise the IKDC subset) play an important role in the defense against Listeria primarily by producing IFN-g in response to IL-12 and IL-18. 4 Recently published experiments show that NK and IKDC cell lineages originate in mice from different primitive lymphoid precursors, supporting the notion that these cells represent a distinct hematopoietic lineage, 5 albeit an homologous cell subset in human beings still defies identification. 6, 7 However, several groups have recently questioned the existence of this cell subset as a separate lineage from NK cells, with the putative antigen presentation function of IKDC at the core of the controversy. [8] [9] [10] For some of these authors, IKDCs may represent an activated status of conventional NK cells. 8 11, 12 is an absolutely essential cytokine for the differentiation and maintenance of memory CD8 + T, NKT and NK cells. 13 IL-15 shows a broad tissue distribution at the mRNA level, but post-transcriptional and intracellular trafficking mechanisms confine functional production mainly to myeloid cells. 14 The effects of IL-15 on NK cells have been studied in detail. 12 IL-15 and IL-15Ra are necessary for the differentiation of NK cells from lymphoid precursors and for their steady-state survival. 13, 15, 16 IL-15 is mitogenic for NK cells, enhances secretion of pro-inflammatory cytokines and upregulates their cytolytic machinery. 12, 17 The multimeric receptor for IL-15 encompasses two signaling subunits IL-2Rb (CD122) and IL-2Rg (CD132), while the high-affinity specific chain (IL-15Ra) makes limited or no contribution to signaling. The main role of IL-15Ra is trans-presenting its bound cytokine to the signaling receptor subunits on the membrane of a juxtaposed cell. 18 In this sense, IL-15 complexed to IL15Ra on the plasma membrane of an antigen-presenting cell acts more as a co-stimulatory molecule rather than as a soluble cytokine. 19 Trans-presentation events can be mediated by monocytes and DCs, which are the main producers of this cytokine. 18, 20 Hydrodynamic injection is a relatively simple and useful technique in rodents for gene delivery in vivo that relies in rapidly injecting a solution containing naked DNA into the tail veins. 21 As a result of the hydrostatic pressure and the reflux of the DNA solution from the cava to the hepatic veins, the plasmid extravasates from liver sinusoids and enters into hepatocytes. The procedure gives rise to 2-20% hepatocytes productively transfected and has been used to express in vivo cytokines, such as sFLT-3L 22 and IL-2. 23 Several ex vivo gene transfer strategies involving IL-15 have been studied in mice, 12, 19, [24] [25] [26] [27] [28] [29] but in vivo gene transfer to attain circulating systemic levels of IL-15 has not been tried and can be a valuable tool to study the biology of this cytokine.
IL-15
The complete lack of DX5 + and NK1. 
Results
Hydrodynamic delivery to the liver of a plasmid encoding hIL-15 results in transient circulation of this cytokine
Hydrodynamic-based gene delivery has been shown to provide a simple and efficient way to express biologically active proteins in living mice. 21 To evaluate the immunological activities of hydrodynamic-based IL-15 gene delivery in mice, an expression plasmid encoding for a secretable form of human IL-15 (hIL-15) was produced under the transcriptional control of the earlyintermediate cytomegalovirus promoter. 28 A previous study had shown that human and mouse IL-15 provoked similar responses in mice. 30 First, we studied transfection of liver tissue cells and persistence of hIL-15-encoding plasmid upon hydrodynamic-based delivery by quantitative PCR. Mice were injected with 10 mg of naked plasmid containing with or without (control plasmid) the hIL-15 cDNA. A considerable amount of hIL-15 cDNA was detected in the liver tissue during the first 24 h following administration of the plasmid (Figure 1a ), followed by a steady decline in the quantity of administered DNA. However, low yet measurable levels of hIL-15 cDNA could still be detected 8 days after hydrodynamic injection. The IL-15 gene sequence (c) Serum concentrations of hIL-15 after hydrodynamic plasmid delivery. Mice were injected with 10 mg of either hIL-15 plasmid or control plasmid as in (a, b). Serum samples were collected at various time points after injection and hIL-15 was determined by enzyme-linked immunosorbent assay (ELISA). To control the effect of the hydrodynamic injection, a group of mice received 1.8 ml of saline solution by hydrodynamic injection into the tail vein (saline). Mouse IL-15 was undetectable in these samples (data not shown). Data are representative of three experiments similarly performed with two mice at each time point and condition.
IKDC response to IL-15 liver gene transfer
A Arina et al detected corresponds to the transgene and not to the host gene since no IL-15 DNA was amplified in the group of mice that received the control plasmid ( Figure 1a ). Foreign gene expression could be detected by quantitative reverse transcription-PCR following hydrodynamic hIL-15 cDNA delivery (Figure 1b) . The kinetics of hIL-15 gene expression closely resembled the kinetics of detection of hIL-15-encoding plasmid in liver tissues, with high levels of hIL-15 mRNA during the first 24 h followed by low but measurable levels of gene expression that persisted up to day 5. Administration of hIL-15 expression plasmid resulted in a transient expression of hIL-15 whose concentration peaked in serum 8 h after injection (reaching up to 8 ng ml
À1
) and was detectable through 48 h (Figure 1c) . The loss of the hIL-15-encoding plasmid in the liver together with the short half-life of IL-15 is conceivably the main causes for the fast decline of this cytokine in the serum. No mouse IL-15, IFN-g, tumor necrosis factor (TNF)-a, IL-12(p70) were detected in serial serum samples drawn after hydrodynamic delivery of either hIL-15-encoding or control plasmid (data not shown). Similarly, we checked the possible induction of host IL-2, since this cytokine shares with IL-15 two receptor subunits and some biological functions. However, very low levels (below 50 pg ml
) of mouse IL-2 could be detected in these serum samples (data not shown). Moreover, such small quantities of mIL-2 were similar in the IL-15 and the control plasmid-treated mice, hence excluding a role of IL-2 on the effects of IL-15 hydrodynamic gene transfer.
Repeated hydrodynamic doses attain similar circulating levels of hIL-15
It was then investigated whether hydrodynamic hIL-15-encoding plasmid delivery allows repeated injections. Both wild-type (WT) or immunodeficient RAG1 À/À mice received a hydrodynamic injection of 10 mg of hIL-15 expression plasmid followed by a second hydrodynamic administration of the same doses of plasmid at day 7. Circulating levels of hIL-15 were determined at 6 h following each injection. As depicted in Figure 2 , the levels of circulating hIL-15 detected 6 h after the hydrodynamic injection were similar in WT and RAG1 À/À mice, regardless of whether those particular mice had received one or two injections. This indicates that hIL-15 expression levels are not affected by an adaptive immune response against the xenogenic transgene.
hIL-15 hydrodynamic gene delivery expands total NK1.1 + CD3 À cells and IKDC subsets in both liver and spleen
The levels of hIL-15 achieved by hydrodynamic gene delivery suggested that this approach would induce immunological effects. To evaluate the biological activity of the IL-15 produced upon hydrodynamic injection, the frequency of NK1.1 + CD3 À cells (majority NK cells) was determined in spleen and liver after hydrodynamic delivery of hIL-15 cDNA. An increase in the percentage of total NK1.1 + CD3 À cells was observed in both liver and spleen, although the expansion in the liver was more dramatic (Figures 3a and b) . These increases remained sustained for at least 5 days. Curiously, 24 h after the hydrodynamic injection, the frequency of NK1. IKDCs also express IL-2/IL-15 receptor b chain (CD122) and it has been shown that CD122 is necessary for the development of IKDCs. 1 We wondered if IL-15 could also control expansion and activation of IKDCs. Thus, we analyzed the percentage of IKDCs in liver and spleen upon hydrodynamic injection of hIL-15-encoding plasmid. As depicted in Figures 3a and b , an increase in the percentage of IKDCs (NK1.1
) was observed in the liver and spleen of mice treated with hIL-15 cDNA plasmid (Figure 3b ). These increases were sustained in both organs for at least 5 days. Curiously, as also happens to NK cells (Figure 3b ), a slight increase in the number of hepatic IKDCs was observed at 24 h after the hydrodynamic injection of control plasmid but not of saline solution (Figure 3b ).
We further determined the effect of hIL-15 delivered by hydrodynamic injection on the proliferation of NK cells and IKDCs using an adoptive transfer model. Carboxyfluorescein succinimidyl ester (CFSE)-labeled DX5 + -enriched splenocytes were transferred to WT mice that were pretreated (8 h before) with a hydrodynamic injection of hIL-15-encoding or control plasmid. Percentages of dividing donor NK1.1 +
CD3
À cells and IKDCs were determined in the spleen at day 3 after injection ( Figure 3c ). Gated NK1.1
À cells in the spleen readily proliferated in response to hydrodynamic gene delivery . Therefore, the increases in number of both conventional NK cells and IKDCs can be at least in part explained in terms of proliferation from already differentiated cells, although differentiation from lymphoid progenitors is also a likely mechanism. In this experimental setting, rapid differentiation from conventional resting NK cells, as recently proposed by Vosshenrich et al. 8 could also contribute to some extent to our observation.
Hydrodynamic hIL-15 gene delivery activates IKDCs
IL-15 controls not only the expansion but also the activation of NK cells. IKDCs share properties of both NK cells and DCs. It has been reported that IKDCs express several surface markers upregulated in activated NK cells, such as TRAIL and NKG2D.
1,2 CD137 has also been associated with the activation of both NK cells and DCs and to date no data are available on its expression on IKDCs. We asked whether IL-15 modulates the expression of these four surface markers on IKDCs. As , no changes could be observed in the studied activation markers except for NKG2D, which was specifically upregulated by the hIL-15 plasmid (data not shown). Upon injection of either hIL-15-encoding or control plasmid, there was a slight downregulation of the expression of I-A b major histocompatibility complex class II molecules on IKDCs that was not specific for IL-15 and is probably related to the bacterial DNA backbone of the plasmid (data not shown).
Hydrodynamic hIL-15 gene transfer enhances the cytotoxic activity of IKDCs
In addition to the induced increase in cell numbers and in the expression of activation markers on NK and IKDCs, the cytolytic activity of these cells was explored. Total splenocytes from mice treated with hIL-15-encoding or control plasmid were used as effectors in standard 51 Cr release assays using YAC-1 cells as targets. As depicted in Figure 5a , hydrodynamic delivery of hIL-15 cDNA resulted in an enhancement of the lytic activity of splenocytes against the prototype NK cell target, YAC-1. This lytic activity peaked at day 3 and remained above background for at least 5 days after hydrodynamic injection (Figure 5b ).
It has been previously shown that upon interaction with NK-sensitive cells, IKDCs secrete high levels of IFN-g and mediate lysis of target cells. 2 To determine if hydrodynamic administration of hIL-15 cDNA increases both the cytolytic activity and the IFN-g production of this particular subpopulation, IKDCs were sorted by fluorescence-activated cell sorting (FACS) from the spleen of mice treated with hIL-15-encoding or control plasmid. Then, their cytolytic activity against YAC-1 cells was compared to that of purified NK cells (excluding the IKDC subset). As shown in Figure 5c , cytolytic activity of IKDCs, and to a much lesser extent of NK cells, was enhanced on a cell-per-cell basis upon hydrodynamic administration of IL-15 cDNA. However, IFN-g secretion capacity of both NK cells and IKDCs in response to YAC-1 cells was not increased or even was decreased on a per cell basis by hIL-15 cDNA hydrodynamic delivery (Figure 5d ). NK cells and IKDCs from mice treated with the IL-15 plasmid also showed a partial decrease in their capacity to produce IFN-g when stimulated in culture by a combination of IL-12 plus IL-15 (inset in Figure 5d ).
The hydrodynamic transfer of hIL-15 plasmid provides a more efficient method to observe the effects of IL-15 on IKDC and conventional NK cells than the systemic administration of the protein
The hydrodynamic delivery of DNA has been often used for its simplicity and efficiency to get persistent levels of IKDC response to IL-15 liver gene transfer A Arina et al a certain cytokine in vivo. 21 Because of the low molecular weight of most cytokines (which determines their rapid renal clearance from serum), these pharmacokinetics would be difficult and expensive to get through the systemic administration of the protein.
To check to what extent this was true in our case, we compared the biologic effects observed at day 3 after a single hydrodynamic injection or the administration of two doses of recombinant hIL-15 protein. As can be seen in Figure 6a , the hydrodynamic administration gets a high, persistent expression of the protein during the first hours that sharply contrasts with the rapid drop in levels observed 30 min after the peak achieved by the protein. To get the expression peak simultaneously, the first dose of the protein was administered 7.5 h after the hydrodynamic injections. Because hIL-15 is detected during 48 h after a hydrodynamic injection, a second dose of protein was administered to mice 24 h later. For unknown reasons, this second injection never reached the levels attained by the first dose but resembled the hydrodynamic injection plot in terms of maximum cytokine levels. Again, the concentration of hIL-15 24-48 h after the injection (Figure 6b) . Similarly, the protein showed a lesser effect on the expression of TRAIL and 4-1BB activation markers when compared to the hydrodynamic delivery of the plasmid (Figure 6c ). This lower activation status was also observed in the natural cytotoxicity exerted by total splenocytes of mice treated with the protein (Figure 6d) . Therefore, the hydrodynamic gene transfer of hIL-15 as a Taken together, all these data indicate that hydrodynamic delivery of IL-15 cDNA provides a useful experimental method to study the in vivo effects of IL-15 on IKDCs and NK cells.
Discussion
This study proves the concept that liver gene transfer in mice provides a source of IL-15 that thereby impacts the biology of IKDCs and NK cells upregulating both their numbers and their cytolytic function.
The liver seems to be the organ in which the biological effects of this gene transfer approach are more pronounced. Local concentrations of IL-15 at the source point are conceivably higher and the cytokine may last longer in this organ where it might remain adsorbed onto constitutively expressed IL-15Ra. 31 In this study, we identify small numbers of IKDCs residing in the untreated liver that increase their number following transient gene expression of hIL-15 in this organ. From now on, IKDCs should be considered an additional cellular player in the incompletely understood functions of the liver immune system. 32 Functional plasticity seems to be a characteristic feature of IKDCs 1 and NKDCs 33 because these cells seem to modulate the expression of particular sets of receptors depending on the stimulus provided to them. In our study, we observed an upregulation of activation markers typically expressed by cytotoxic effector cells, TRAIL and CD137, following the administration of hIL-15 gene. Interestingly, IL-15 increases surface expression levels of TRAIL, a molecule reportedly involved in the tumoricidal effects of IKDCs promoted by IL-2 plus imatinib. 2, 6 The surface antigen CD137 was constitutively found on these cells and its expression was increased as a result of IL-15 gene therapy. Hence, it will be interesting to investigate whether the therapeutic cellular immunity enhanced by agonistic anti-CD137 monoclonal antibodies is in part mediated via these cells as is the case with NK cells. 34 Upregulation of these activation markers by IKDCs correlated with an augmented cytotoxic activity. Nonetheless, under IL-15 in vivo gene transfer there was an unexpected partial reduction in the capability of sorted NK cells and IKDCs to produce IFN-g in culture in response to tumor cells. This indicates that hydrodynamic IL-15 gene transfer differentially modulates cytokine production and cytotoxicity as elicited by YAC-1 cells.
In our model, IL-15 expression is transient and circulating levels are relatively modest. Mechanisms mediating extinction of gene expression encompass loss of the plasmid vector and probably silencing of the cytomegalovirus promoter. 35 Higher and more sustained levels of circulating IL-15 upon gene transfer could be achieved by exogenously regulatable promoters targeting transcription to the liver and using liver-tropic viral vectors such as those based on 'gut-less' adenoviruses or adeno-associated viruses. 36 Alternatively, a way to optimize the pharmacokinetics of IL-15 is to complex it with an IgFc chimeric protein that encompasses IL-15Ra, in such a way that renal elimination is retarded and trans-presentation is favored. 30, 37 Overall, hydrodynamic gene transfer was by far a better method to get sustained levels of the cytokine in serum, when compared to the systemic administration of the protein.
Therefore, hydrodynamic gene delivery represents a highly efficient method to study the effects of IL-15 on IKDC and conventional NK cells, especially in the liver. Despite the transient nature of gene expression in our system, we were able to observe biological effects at time points in which no detectable IL-15 could be found as protein or as mRNA. This could be due to the fact that circulating IL-15 can be trapped and trans-presented adsorbed onto recycling IL-15Ra in cells such as DCs or stromal fibroblastic cells. 20 Alternatively, this could happen because a short in vivo exposure to IL-15 imprints a response in the IKDCs and NK cells that is detected at later time points. Although we readily observe IL-15 trans-presentation using DCs pulsed in vitro with recombinant hIL-15, we could not ascertain this phenomenon in DCs isolated from the spleen following hydrodynamic gene transfer of hIL-15 in vivo (data not shown). Higher levels of circulating cytokine could be critical for this purpose as proposed by Sato et al. 38 It remains to be seen if IKDCs also sense IL-15 via DC-mediated trans-presentation.
Contrary to IL-2, 22 the hydrodynamic delivery of IL-15 did not show curative effects in several murine cancer models (B16F10, RENCA, CT26, RMA-S; data not shown). This difference might be related to the lower levels of cytokine achieved by our plasmid, or to an intrinsic inferiority of IL-15 when compared to IL-2 in terms of activation of anti-tumor functions. In this regard, NKDC expanded in IL-15 had to be pretreated with IL-12 plus IL-18 to exhibit antitumor activity. 39 In any case, rodent data showing lesser toxicity and a much more consistent immunostimulatory profile back the choice of IL-15 over IL-2 for immunotherapy. 40 Indeed, the hydrodynamic hIL-15 gene transfer has clear biologic effects in our hands, and we believe that it could be used in combination with other immunotherapy agents to enhance their effectiveness, as has already been documented with the recombinant protein. 41, 42 Our study indicates that these beneficial effects could be greatly promoted by the higher efficiency of the hydrodynamic injections. Also, it would be interesting to study the effects of hIL-15 liver gene transfer of on other cell populations, such as memory T cells, due to their reported dependence on IL-15. 13 These points are currently under exploration.
The scanty numbers of IKDCs make their isolation and study very difficult and therefore administration of IL-15 as a soluble cytokine or by gene transfer could be a valuable tool to explore IKDC's biology, much in the same ways as sFLT-3L hydrodynamic gene transfer was useful for the study of different DC populations. 22, 43 As a tool to increase IKDC numbers, hydrodynamic gene transfer of IL-15 can be valuable to address and settle the polemics on the true nature of IKDCs. 7, 44 From this experimental point of view, hIL-15 can be readministered to mice in successive hydrodynamic injections of the encoding plasmid, thereby achieving comparable levels of circulating cytokine.
As a whole, this study (i) demonstrates that the liver can be used as an endogenous source of secretable IL-15 following hepatocyte gene transfer and (ii) provides experimental evidence for a functional link between 
Materials and methods
Mice and cell lines C57BL/6 mice (6-10 weeks old) were purchased from Harlan Laboratories (Barcelona, Spain). RAG1 À/À mice on C57BL/6 background from the Jackson Laboratory (Bar Harbor, ME, USA) were bred in our animal facility. All animal procedures were conducted under institutional guidelines (study approval number 003/02) that comply with national laws and policies. YAC-1 cells were obtained from American Type Culture Collection.
Plasmids and hIL-15 protein
The pVkL/IL-15IRESneo expression plasmid, which carries a modified cDNA encoding for hIL-15 pre-protein bearing the IgK light-chain signal peptide (VkL) under the transcriptional control of the cytomegalovirus promoter/enhancer (hIL-15 plasmid), and the empty pIRES1neo (control plasmid) were produced and purified as described. 28 hIL-15 recombinant protein purchased from Peprotech (Rocky Hill, NJ, USA) was intraperitoneally injected in 1 mg doses, diluted in 200 ml of phosphatebuffered saline (PBS) per dose.
Hydrodynamic injections

C57BL/6 or RAG1
À/À mice received an intravenous injection (tail vein) of 10 mg of either hIL-15-encoding or control plasmid in a volume of 100 ml kg À1 using a 27-G needle at a rate of 0.4 ml s À1 , as previously described. 22 
Antibodies and flow cytometry
Cells isolated from liver and spleens were pretreated with anti-CD16/32 (eBioscience, San Diego, CA, USA) to reduce nonspecific staining. Monoclonal antibodies to the following mouse antigens were conjugated to fluorescein isothiocyanate, phycoerythrin (PE), PE-cyanine7 (PE-Cy7), allophycocyanin (APC) or biotin: CD3 (145-2C11), CD11c (HL3), NK1.1 (PK-136), B220 (RA3-6B2), GR1 (RB6-8C5), I-A b (KH74), CD137 (17B5) and appropriate isotype controls were obtained from BD Biosciences (San Diego, CA, USA); NKG2D (MI6) and TRAIL (N2B2) were purchased from eBioscience. Biotinylated antibodies were visualized with streptavidin (Sav)-APC-Cy7 (BD Biosciences). FACSAria and FACSCalibur cytometers were used for cell acquisition, and data analysis was performed using FACS DiVa (BD Biosciences) and FlowJo 7.2.1 (Tree Star Inc., Ashland, OR, USA).
Total RNA and DNA purification and real-time PCR Total RNA was extracted from liver tissue using TRI reagent (Sigma-Aldrich, Barcelona, Spain). We treated RNA with DNaseI (Gibco-BRL, Gaithersburg, MD, USA) prior to reverse transcription with M-MLV reverse transcriptase (Gibco-BRL) in the presence of RNaseOUT (Gibco-BRL). Real-time PCR was performed using an iCycler (Bio-Rad, Hercules, CA, USA) and the iQ SYBR Green Supermix (Bio-Rad). hIL-15 cDNA was amplified using primers GCCAACTGGGTGAATGTAATAAG and GAATCAATTGCAATCAAGAAGTG specific for hIL-15. Mouse b-actin cDNA was amplified as control using primers CGCGTCCACCCGCGAG and CCTGGTGCCTA GGGCG. Alternatively, total DNA was isolated from liver tissue using the DNeasy tissue Kit (Qiagen, Madrid, Spain). hIL-15 DNA was amplified by real-time PCR using the same pair of primers described above. Mouse genomic DNA for SOCS3, used as control, was amplified using primers TACCAGCTGGTGGTGAACGC and GCGGCATGTAGTGGTGCACC. To monitor the specificity, final PCR products were analyzed by melting curves and electrophoresis. The amount of hIL-15 was expressed as arbitrary units defined as the n-fold difference relative to the control gene b-actin (for transcription) or SOCS3 (for genomic DNA) 2C t Â100, where DC t represents the difference in threshold cycle between the control and target genes).
Cell isolation
Liver non-parenchymal cells and splenocytes were isolated from mice injected with hIL-15-encoding or control plasmid at the indicated time points. Briefly, spleens were incubated in collagenase and DNase (Roche, Basel, Switzerland) for 15 min at 37 1C, and then both livers and spleens were mechanically disrupted before being passed through a sterile 70-mm nylon mesh filter (BD Falcon, San Jose, CA, USA). Hepatocytes were excluded from the liver samples by discarding the pellets after a single-step Percoll gradient (GE Healthcare, Chalfont St Giles, UK). In either case, erythrocytes were lysed with ACK buffer. In certain experiments, splenocytes were enriched in DX5 + cells using immunomagnetic beads according to the manufacturer's protocol (Miltenyi Biotec, Bergisch Gladbach, Germany). At this step, the cell suspension was composed of 50-70% of NK cells, including 3-8% of IKDCs. The NK cells and IKDCs were further purified on a FACSAria sorter on the basis of the expression of NK1. 
Ex vivo analysis of effector function
To determine IFN-g secretion capacity, FACS-sorted NK cells and IKDCs from mice treated with hIL-15-encoding or control plasmid were incubated for 72 h with medium alone or with YAC-1 cells (10 4 targets per well) at a 10:1 E:T ratio. In both cases, human IL-2 (Chiron, Emeryville, CA, USA) was present at 100 IU ml À1 . When indicated mIL-15 (R&D, Minneapolis, MN, USA) at 50 ng ml À1 and mIL-12 (Peprotech) at 1 ng ml À1 were added to the cultures. 1 Cr-release was counted using TopCount NXT (PerkinElmer, Waltham, MA, USA).
Enzyme-linked immunosorbent assay
hIL-15, mTNF-a, mIFN-g, mIL-12(p70) and mIL-2 from individual sera and mouse IFN-g content in the supernatants from the ex vivo cultured cells were quantified by commercial enzyme-linked immunosorbent assay (ELI-SA) (OptEIA; BD Biosciences). The ELISA pair OptEIA set for hIL-15 shows no cross-reactivity with any of the cytokines tested (for example, mouse IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 p70, IL-15, GM-CSF, IFN-g, MCP-1, TCA-3, TNF) according to the manufacturer. For the quantification of mIL-15, an ELISA set from R&D was used.
Abbreviation IKDC, interferon-producing killer dendritic cell
